P53-null stromal fibroblasts promote more efficient tumor growth in a murine prostate cancer model (14) and there is a reduced latency of tumor formation in xenografts in p53-deficient mice compared to animals with wild-type p53 (15). This evidence concerns the gene TP53 and prostate carcinoma.